A detailed history of Smith, Moore & Co. transactions in Mckesson Corp stock. As of the latest transaction made, Smith, Moore & Co. holds 401 shares of MCK stock, worth $337,678. This represents 0.03% of its overall portfolio holdings.

Number of Shares
401
Previous 391 2.56%
Holding current value
$337,678
Previous $286,000 8.04%
% of portfolio
0.03%
Previous 0.03%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$659.01 - $772.54 $6,590 - $7,725
10 Added 2.56%
401 $309,000
Q1 2025

May 14, 2025

BUY
$566.21 - $672.99 $14,155 - $16,824
25 Added 6.83%
391 $263,000
Q4 2024

Feb 12, 2025

BUY
$482.27 - $628.5 $176,510 - $230,031
366 New
366 $208,000
Q2 2024

Aug 14, 2024

BUY
$518.81 - $607.81 $184,696 - $216,380
356 New
356 $207,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $121B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Smith, Moore & Co. Portfolio

Follow Smith, Moore & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Moore & Co., based on Form 13F filings with the SEC.

News

Stay updated on Smith, Moore & Co. with notifications on news.